The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients
Open accessAbstract
We characterized metabolic and mitogenic signaling pathways in isolated skeletal muscle from well-matched type 2 diabetic and control subjects. Time course studies of the insulin receptor, insulin receptor substrate (IRS)-1/2, and phosphatidylinositol (PI) 3-kinase revealed that signal transduction through this pathway was engaged between 4 and 40 min. Insulin-stimulated (0.6-60 nmol/l) tyrosine phosphorylation of the insulin receptor beta-subunit, mitogen-activated protein (MAP) kinase phosphorylation, and glycogen synthase activity were not altered in type 2 diabetic subjects. In contrast, insulin-stimulated tyrosine phosphorylation of IRS-1 and anti-phosphotyrosine-associated PI 3-kinase activity were reduced 40-55% in type 2 diabetic subjects at high insulin concentrations (2.4 and 60 nmol/l, respectively). Impaired glucose transport activity was noted at all insulin concentrations (0.6-60 nmol/l). Aberrant protein expression cannot account for these insulin-signaling defects because expression of insulin receptor, IRS-1, IRS-2, MAP kinase, or glycogen synthase was similar between type 2 diabetic and control subjects. In skeletal muscle from type 2 diabetic subjects, IRS-1 phosphorylation, PI 3-kinase activity, and glucose transport activity were impaired, whereas insulin receptor tyrosine phosphorylation, MAP kinase phosphorylation, and glycogen synthase activity were normal. Impaired insulin signal transduction in skeletal muscle from type 2 diabetic patients may partly account for reduced insulin-stimulated glucose transport; however, additional defects are likely to play a role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [26]
Experimental — accuracy not yet measuredIn the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [165]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [165]
In the citing paper
“In insulin resistant individuals with T2DM, glucose transport activity is severely impaired [156, 181, 182, 187–189].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Thomas, J. A., Schlender, K. K., & Larner, J. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90127-9 · Cited by 1,198
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459
A microfluorometric method for the determination of free fatty acids in plasma
Miles, J., Glasscock, R., Aikens, J., Gerich, J. E., & Haymond, M. W. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38029-9 · Cited by 329
Rothman, D. L., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115686 · Cited by 327
Vaag, A., Henriksen, J. E., & Beck-Nielsen, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115656 · Cited by 299
Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S., Elton, C. W., & Caro, J. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113622 · Cited by 296
Kelley, D. E., Mintun, M. A., Watkins, S. C., Simoneau, J. A., Jadali, F., Fredrickson, A., Beattie, J., & Thériault, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118724 · Cited by 228
Cited by
Sorted by citations
Items 201–300 of 375
Kawano, T., Nomura, M., Nisikado, A., Nakaya, Y., & Ito, S. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.06.004 · Cited by 25
Insulin Resistant States and Insulin Signaling
Vollenweider, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.173 · Cited by 26
Carey, A. L., Lamont, B. J., Andrikopoulos, S., Koukoulas, I., Proietto, J., & Febbraio, M. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00267-5 · Cited by 23
Yan, Y., Deng, T., Wan, X., Ouyang, J., Liu, M., & Mao, X. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1580 · Cited by 24
Ijuin, T., Hatano, N., Hosooka, T., & Takenawa, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.009 · Cited by 25
Novel aspects of adipocyte-induced skeletal muscle insulin resistance
Eckardt, K., Sell, H., & Eckel, J. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802404761 · Cited by 24
Oleszczak, B., Szablewski, L., & Pliszka, M. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.012 · Cited by 23
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Ho, R. C., Davy, K. P., Hickey, M. S., Summers, S. A., & Melby, C. L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2002 · Cited by 23
Globular adiponectin stimulates glucose transport in type 2 diabetic muscle
Kuoppamaa, H., Skrobuk, P., Sihvo, M., Hiukka, A., Chibalin, A., Zierath, J. R., & Koistinen, H. A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.883 · Cited by 23
Self-citationVenugopal, J., Hanashiro, K., Yang, Z., & Nagamine, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405278101 · Cited by 22
Modified UCN2 Peptide Acts as an Insulin Sensitizer in Skeletal Muscle of Obese Mice
Borg, M. L., Massart, J., Schönke, M., Barbosa, T. D. C., Guo, L., Wade, M. R., Alsina‐Fernandez, J., Miles, R. R., Ryan, A., Bauer, S. M., et al. (2019) · Diabetes · doi:10.2337/db18-1237 · Cited by 21
Self-citationLefai, É., Roques, M., Véga, N., Laville, M., & Vidal, H. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600117 · Cited by 20
Jevtovic, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s328694 · Cited by 22
GLUT4's itinerary in health & disease.
McCarthy, A. M., & Elmendorf, J. S. (2007) · PubMed · Cited by 20
Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways
Jeong, H., Koh, A., Lee, J., Park, D., Lee, J. O., Lee, M. N., Jo, K.-J., Tran, H. N. K., Kim, E., Min, B.-S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18081-8 · Cited by 20
Luo, Q., Xiao, Y., Alex, A., Cummins, T., & Bhatwadekar, A. D. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26045 · Cited by 19
Hao, Y., Tong, Y., Guo, Y., Lang, X., Huang, X., Xie, X., Guan, Y., & Li, Z. (2021) · Pharmacopsychiatry · doi:10.1055/a-1351-0566 · Cited by 21
Nadeau, K. J., Ehlers, L. B., Aguirre, L. E., Reusch, J. E. B., & Draznin, B. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00696.x · Cited by 19
Verma, M. K., Yateesh, A. N., Neelima, K., Pawar, N., Sandhya, K., Poornima, J., Lakshmi, M. N., Yogeshwari, S., Pallavi, P. M., Oommen, A. M., et al. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-255 · Cited by 20
Intracellular pH Regulation of Skeletal Muscle in the Milieu of Insulin Signaling
Posa, D. K., & Baba, S. P. (2020) · Nutrients · doi:10.3390/nu12102910 · Cited by 19
Bouzakri, K., Roques, M., Debard, C., Berbe, V., Rieusset, J., Laville, M., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1428-1 · Cited by 18
Alipourfard, I., Bakhtiyari, S., Gheysarzadeh, A., Renzo, L. D., LORENZO, A. D., Mikeladze, D., & Khamoushi, A. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200427102209 · Cited by 18
Roy, J. R., Janaki, C. S., Jayaraman, S., Vijayalakshmi, P., Balaji, T., Vijayamalathi, M., & Veeraraghavan, V. P. (2022) · Nutrients · doi:10.3390/nu14194181 · Cited by 17
Link between insulin resistance and skeletal muscle extracellular matrix remodeling
Aleksandrowicz, R., & Strączkowski, M. (2023) · Endocrine Connections · doi:10.1530/ec-23-0023 · Cited by 16
Friedrichsen, M. H., Poulsen, P., Richter, E. A., Hansen, B. F., Birk, J. B., Ribel‐Madsen, R., Stender-Petersen, K. L., Nilsson, E., Beck‐Nielsen, H., Vaag, A. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1795-8 · Cited by 16
Ginsenoside 20(R)-Rg3 stimulates glucose uptake in C2C12 myotubes via CaMKK-AMPK pathways
Kim, D. Y., Yuan, H.-D., Huang, B., Quan, H.-Y., & Chung, S. H. (2010) · Food Science and Biotechnology · doi:10.1007/s10068-010-0182-z · Cited by 17
Skeletal Muscle microRNAs: Roles in Differentiation, Disease and Exercise
Sjögren, R. J. O., Niss, M. H. L. L., & Krook, A. (2017) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-72790-5_6 · Cited by 16
Self-citationQuan, Y., Hua, S., Li, W., Zhan, M., Li, Y., & Lu, L. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117188 · Cited by 14
Insulin resistance and the role of gamma-aminobutyric acid
Rezazadeh, H., Sharifi, M., & Soltani, N. (2021) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_374_20 · Cited by 16
Kawano, Y., Ryder, J. W., Rincón, J., Zierath, J. R., Krook, A., & Wallberg‐Henriksson, H. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1255 · Cited by 15
Self-citationMetabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Karlsson, H., Kasahara, A., Ikeda, M., Chibalin, A., Harada, J., Rydén, M., Krook, A., Kato, M., Kubota, K., & Zierath, J. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154726 · Cited by 14
Self-citationAncu, O., Mickute, M., Guess, N. D., Hurren, N. M., Burd, N. A., & Mackenzie, R. W. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-0396 · Cited by 20
Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
Elsayed, A. K., Vimalraj, S., Nandakumar, M., & Abdelalim, E. M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i3.221 · Cited by 15
Mata-Torres, G., Andrade‐Cetto, A., & Espinoza-Hernández, F. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809994 · Cited by 16
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 14
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch25 · Cited by 17
McCarty, M. F. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1455 · Cited by 13
Kinetic modeling of leucine-mediated signaling and protein metabolism in human skeletal muscle
McColl, T. J., & Clarke, D. C. (2023) · iScience · doi:10.1016/j.isci.2023.108634 · Cited by 12
High insulin levels impair intracellular receptor trafficking in human cultured myoblasts
Bertacca, A., Ciccarone, A., Cecchetti, P., Vianello, B., Laurenza, I., Prato, S. D., & Benzi, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.06.001 · Cited by 12
Jazet, I. M., Ouwens, D. M., Schaart, G., Pijl, H., KEIZER, H. A., Maassen, J. A., & Meinders, A. E. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.017 · Cited by 12
Shashkin, P. N., Wasner, H. K., Ortmeyer, H. K., & HANSEN, B. C. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.218 · Cited by 12
Wadley, G. D., Bruce, C. R., Konstantopoulos, N., Macaulay, S. L., Howlett, K. F., Hawley, J. A., & Cameron‐Smith, D. (2004) · Diabetologia · doi:10.1007/s00125-003-1322-2 · Cited by 12
Furuzono, S., Kubota, T., Taura, J., Konishi, M., Naito, A., Tsutsui, M., Karasawa, H., Kubota, N., & Kadowaki, T. (2021) · Communications Biology · doi:10.1038/s42003-021-02491-6 · Cited by 11
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 11
Schwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 11
Nikolaidis, M. G., Kerksick, C. M., Lamprecht, M., & McAnulty, S. R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/407978 · Cited by 12
Hall, B., Żebrowska, A., Kamiński, T., Stanula, A., & Robins, A. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-110482 · Cited by 11
Gaster, M. (2018) · Apmis · doi:10.1111/apm.12908 · Cited by 12
MicroRNA‑23a‑5p mediates the proliferation and differentiation of C2C12 myoblasts
Zhao, X., Gu, H., Wang, L., Zhang, P., Du, J., Shen, L., Jiang, D., Wang, J., Li, X., Zhang, S., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11475 · Cited by 10
Specificity of insulin signalling in human skeletal muscle as revealed by small interfering RNA
Krook, A., & Zierath, J. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1330-y · Cited by 10
Self-citationSchott, C., Germain, A., Lacombe, J., Pata, M., Faubert, D., Boulais, J., Carmeliet, P., Côté, J., & Ferron, M. (2024) · Diabetes · doi:10.2337/db23-0802 · Cited by 10
Jiang, J. G., Shen, G. F., Li, J., Qiao, C., Xiao, B., Yan, H. M., Wang, D. W., & Xiao, X. (2016) · Gene Therapy · doi:10.1038/gt.2016.85 · Cited by 9
Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases
Sharma, M., Yadav, Y., & Dey, C. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0151 · Cited by 11
Cheng, C., Nakamura, A., Minamimoto, R., Shinoda, K., Tateishi, U., Goto, A., Kadowaki, T., Terauchi, Y., & Inoue, T. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0522-y · Cited by 9
Effect of sub-toxic chlorpyrifos on redox sensitive kinases and insulin signaling in rat L6 myotubes
Shrestha, S., Singh, V. K., Sarkar, S. K., Shanmugasundaram, B., Jeevaratnam, K., & Koner, B. C. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0379-x · Cited by 9
Stanišić, J., Korićanac, G., Kostić, M., Stojiljković, M., Ćulafić, T., Romić, S., & Tepavčević, S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0785 · Cited by 10
Hayata, K., Sakano, K.-I., & Nishinaka, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08148fp · Cited by 9
Hunt, D. G., Ding, Z., & Ivy, J. L. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00017.2002 · Cited by 9
Inhibition of MEK1 signaling pathway in the liver ameliorates insulin resistance
Ueyama, A., Ban, N., Fukazawa, M., Hirayama, T., Takeda, M., Yata, T., Muramatsu, H., Hoshino, M., Yamamoto, M., Matsuo, M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8264830 · Cited by 7
Gao, Q., Jiang, Y., Song, Z., Ren, H., Kong, Y., Wang, C., Zheng, M., Shan, C., & Yang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-67755-7 · Cited by 9
Ijuin, T., & Takenawa, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.031 · Cited by 7
Korsheninnikova, E., Seppälä‐Lindroos, A., Vehkavaara, S., Goto, T., & Virkamäki, A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.272 · Cited by 8
Verma, M. K., Yateesh, A. N., Smitha, R., Neelima, K., Pallavi, P. M., Reddy, M., Poornima, J., Oommen, A. M., Jagannath, M. R., & Somesh, B. P. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-251 · Cited by 8
Mariniello, K., Min, Y., & Ghebremeskel, K. (2018) · Nutrition · doi:10.1016/j.nut.2018.05.033 · Cited by 8
Huang, S., Xu, Y., Peng, W., Cheng, J., Li, H., Shen, L., & Xia, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27743 · Cited by 8
Eckel, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809518-8.00002-7 · Cited by 11
Delays in insulin signaling towards glucose disposal in human skeletal muscle
Grimmsmann, T., Levin, K., Meyer, M., Beck‐Nielsen, H., & Klein, H. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720645 · Cited by 8
Novel Aspects on Insulin Resistance
Anderwald, C. H. (2009) · The Endocrinologist · doi:10.1097/ten.0b013e3181c0479d · Cited by 8
Zierath, J. R., Brady, A. J., MacGregor, K. A., de Zevallos, J. O., & Stocks, B. (2024) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2024.100980 · Cited by 11
Self-citationMubarak, S. A. S., Otaibi, A. A., Qarni, A. A. A., Bakillah, A., & Iqbal, J. (2022) · Nutrients · doi:10.3390/nu14173641 · Cited by 7
Chandirasegaran, G., Elanchezhiyan, C., & Ghosh, K. (2018) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-018-0754-x · Cited by 7
RetractedYan, H. M., Meng, J., Zhang, S., Zhuang, H., Song, Y., Xiao, X., Wang, D. W., & Jiang, J. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.140 · Cited by 7
Role of the AMPKγ3 isoform in hypoxia-stimulated glucose transport in glycolytic skeletal muscle
Deshmukh, A. S., Glund, S., Tom, R. Z., & Zierath, J. R. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00125.2009 · Cited by 7
Self-citationDifferential proteome analysis of diabetes mellitus type 2 and its pathophysiological complications
Sohail, W., Majeed, F., & Afroz, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.009 · Cited by 7
Personalized Molecular Signatures of Insulin Resistance and Type 2 DiabetesPreprint
Larsen, J. K., Stocks, B., Henderson, J., Andersson, D. P., Bäckdahl, J., Hogling, D. E., Stidsen, J. V., Sakamoto, K., Højlund, K., Rydén, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.578994 · Cited by 7
Self-citationNielsen, M. F. (2008) · PubMed · Cited by 6
Microcystin‐LR exposure disrupts the insulin signaling pathway in C2C12 mice muscle cell line
Ma, T., Cao, N., Chen, K., Wang, H., Xu, L., Xu, C., & Huang, P. (2019) · Environmental Toxicology · doi:10.1002/tox.22856 · Cited by 6
Mechanisms by which smoothelin-like protein 1 reverses insulin resistance in myotubules and mice
Tamás, I., Major, E., Horváth, D., Keller, I., Ungvári, Á., Haystead, T., MacDonald, J. A., & Lontay, B. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111663 · Cited by 7
A role for β‐catenin in diet‐induced skeletal muscle insulin resistance
Masson, S. W. C., Dissanayake, W. C., Broome, S. C., Hedges, C. P., Peeters, W., Gram, M., ROWLANDS, D. S., Shepherd, P. R., & Merry, T. L. (2023) · Physiological Reports · doi:10.14814/phy2.15536 · Cited by 5
Keller, I., Ungvári, Á., Kinter, R., Szalmás, F., Kókai, E., & Lontay, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1375771 · Cited by 7
Coghlan, M. P., & Smith, D. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330339 · Cited by 6
Henriksen, T. I., Heywood, S. E., Hansen, N. S., Pedersen, B. K., Schéele, C., & Nielsen, S. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00883 · Cited by 6
Donovan, E. L., Buckels, E. J., Hancock, S. N., Smeitink, D., Oliver, M. H., Bloomfield, F. H., & Jaquiery, A. L. (2016) · Reproductive Sciences · doi:10.1177/1933719116670516 · Cited by 6
Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance test
Frossard, M., Blank, D. W., Joukhadar, C., Bayegan, K., Schmid, R., Luger, A., & Müller, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01360.x · Cited by 6
Shimokawa, T., Kagami, M., Kato, M., Kurosaki, E., Shibasaki, M., & Katoh, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00880-3 · Cited by 5
Insulin and Hypoglycemic Agents
Sleevi, M. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc057 · Cited by 6
Cellular Mechanisms of Insulin Action
Ciaraldi, T. P. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_5 · Cited by 5
Culprits or consequences: Understanding the metabolic dysregulation of muscle in diabetes
O’Reilly, C. L., Uranga, S., & Fluckey, J. D. (2021) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v12.i5.70 · Cited by 5
Fibre Type Dependent Expression of Glucose Transporters in Human Skeletal Muscles
Gaster, M. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_v115_s121.x · Cited by 5
The Role of Gene Therapy and RNA-Based Therapeutic Strategies in Diabetes
Khan, M., Al-Dhaleai, R. E., Alayadhi, S. M., Alhalwachi, Z., & Butler, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110264 · Cited by 4
Revisión de las características clínicas, metabólicas y genéticas de la diabetes mellitus
Guzmán-Juárez, N., & Madrigal‐Santillán, E. (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 4
Athamneh, A. A., Farfoura, M. E., Khaleel, A., & Connie, T. (2025) · Genes · doi:10.3390/genes17010028 · Cited by 3
Insulin and the Physiology of Carbohydrate Metabolism
Pereira, S., & Giacca, A. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_1 · Cited by 3
Role of exercise in the prevention and treatment of metabolic syndrome
Bhat, S., & Balakrishnan, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00012-8 · Cited by 4
Iniguez, A. B., Du, ., & Zhu, M. J. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105106 · Cited by 3
Saraç, F., Berdelı, A., Sarac, S., Savaş, S., Atan, M., & Akçiçek, F. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.34033 · Cited by 3
Klein, H., Müller, R., Drenckhan, M., Schütt, M., Bätge, B., & Fehm, H. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660275 · Cited by 3
Vergotine, Z. (2015) · SUNScholar (Stellenbosch University) · Cited by 3
Jeong, M., McColl, T. J., & Clarke, D. C. (2025) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2025-0017 · Cited by 4
Metadata
- Authors
- Krook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R.
- Affiliations
- Karolinska University Hospital (SE)
- Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2000-02-01
- Volume
- 49
- Issue
- 2
- Pages
- 284-292
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2124948826
- Cited by
- 375
- References
- 19
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 13 · 2020: 7 · 2019: 6 · 2018: 20 · 2017: 11 · 2016: 11 · 2015: 13 · 2014: 15 · 2013: 12 · 2012: 13
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, skeletal muscle, insulin signaling, insulin receptor, IRS-1, insulin receptor substrate 2, phosphatidylinositol 3-kinase, glucose transport, mitogen-activated protein kinase, glycogen synthase, tyrosine phosphorylation, insulin resistance
- MeSH terms
- Biological Transport, Diabetes Mellitus, Type 2, Glucose, Glycogen Synthase, Humans, Insulin, Male, Middle Aged, Phosphoproteins, Phosphorylation, Receptor, Insulin, Time Factors, Tyrosine, Signal Transduction, Muscle, Skeletal, Phosphotyrosine, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review